Results 31 to 40 of about 2,299 (157)

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome

open access: yesExperimental Hematology & Oncology, 2022
VEXAS (vacuoles, E1 enzyme, X-linked, auto-inflammatory, somatic) syndrome is an inflammatory disorder with hematological and systemic features. A recent study demonstrated that the dermal infiltrate in neutrophilic dermatosis from VEXAS patients is ...
Valentin Lacombe   +6 more
doaj   +1 more source

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 [PDF]

open access: yesBlood Advances, 2021
Abstract Somatic mutations in UBA1 involving hematopoietic stem and myeloid cells have been reported in patients with the newly defined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome. Here, we report clinical hematologic manifestations and unique bone marrow (BM) features in 16 patients with VEXAS. All patients
Ifeyinwa Emmanuela Obiorah   +19 more
openaire   +2 more sources

Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations. [PDF]

open access: yesLeukemia
Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a severe inflammatory and hematologic disease caused by somatic mutations in UBA1 . Canonical pathogenic mutations at UBA1 p.Met41 (M41) lead to the ...
Sakuma M   +9 more
europepmc   +3 more sources

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

open access: yesCell Reports Medicine, 2023
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin-like modifier activating enzyme 1 (UBA1) gene. To elucidate VEXAS pathophysiology, we performed transcriptome sequencing of single bone marrow mononuclear cells and hematopoietic stem ...
Zhijie Wu   +18 more
openaire   +2 more sources

A novel Xp11.22–22.33 deletion suggesting a possible mechanism of congenital cervical spinal muscular atrophy

open access: yesMolecular Genetics & Genomic Medicine, 2021
Background Congenital cervical spinal muscular atrophy (CCSMA) is a rare, nonprogressive, neurogenic disorder characterized by symmetric arthrogryposis and motor deficits mainly confined to upper extremities. Since its first proposal by Darwish et al. 39 
Jingwei Liu   +3 more
doaj   +1 more source

Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome [PDF]

open access: yesAmerican Journal of Clinical Pathology
CARLOS J Suarez   +2 more
exaly   +2 more sources

The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
The VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently described X-linked autoinflammatory condition caused by a somatic mutation of the UBA1 gene and characterized by an evolving phenotype. This includes inflammatory
Andreas Himmelmann, Rolf Brücker
doaj   +1 more source

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia

open access: yesCase Reports in Hematology, 2023
VEXAS syndrome stands for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The syndrome is a combined hematological and rheumatological condition caused by a somatic mutation in the UBA1.
Janne Austestad   +5 more
doaj   +1 more source

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.

open access: yesArthritis Research & Therapy, 2022
Sugiyama et al. recently described in “Latent class analysis of 216 patients with adult-onset Still’s disease,” baseline characteristics, laboratory tests, treatment, relapse, and death of adult-onset Still’s disease (AOSD) patients from a Japanese ...
Marion Delplanque   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy